Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient focused benefit risk assessment�� why when how should epidemiologists get
… Data Processing Data Protection Security and Controls Risk Management Data Breach Management Records Management The … in the legitimate interests of RTI-HS (Article 6.1.f), as when we process personal data consistent with our business … that require completion of a Data Protection Impact Assessment (DPIA) when the processing of personal data of EU …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… Collaboration Agreement, clients have the opportunity to benefit from enhanced analytical and technical capabilities focused on specific clinical inquiries or outcomes. “We see … technology, precision medicine, healthcare analytics, patient engagement solutions, population health and …
… session BEST Collaborator Perspectives. The session focused on the BEST System’s work with partners to support … inferential studies. Panelists and moderators emphasized how lessons learned during the COVID-19 pandemic can prepare …
… busy medical professionals and payers, multiple audiences benefit from having access to information about your research … walk you through best practices and special considerations when writing them. From this presentation, you will learn: … benefits of disseminating PLS to achieve meaningful patient involvement in drug or device development, …
… understand the potential implications of what will emerge when the guidelines have been finalised. Anne Heyes, Vice … strategies and evidence generation. Below, she shares how she is seeing product developers respond to Joint Clinical Assessment (JCA) regulation and Medicare price negotiations. …
… of the product or new use Product pricing information Patient utilization projections (e.g., epidemiological data … for the product or new use has been submitted to FDA, or when submission is planned) For communications that include … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; …
… There’s a lot of flexibility with the working hours. If I get to the office late one morning because of a doctor’s … flexibility in work hours allows me to take care of my son when he is with me: I can make my work schedule compatible …
… who were receiving hemodialysis. We wanted to understand how the unique healthcare utilization patterns of patients … patterns of regular healthcare interaction may influence when and how often diagnoses are recorded. We identified influenza …
… the Recording Trends in EMA and FDA Labeling Based on Patient-Reported Outcomes (PROs) A recent review of labels … measures? • What are the main challenges sponsors face when including PRO-related endpoints in cancer clinical research? And how can these challenges be overcome? • What are the emerging …